Brean Murray Carret & Co. downgraded American Oriental Bioengineering Inc. (NYSE: AOB) from Buy to Hold.

Brean analyst says, "Brean ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE